A detailed history of Cibc Bancorp Usa Inc. transactions in Incyte Corp stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 23,374 shares of INCY stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,374
Holding current value
$2.43 Million
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 21, 2025

SELL
$67.27 - $86.96 $48,838 - $63,132
-726 Reduced 3.11%
22,648 $1.92 Million
Q3 2025

Nov 12, 2025

BUY
$67.27 - $86.96 $1.57 Million - $2.03 Million
23,374 New
23,374 $1.98 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $23.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cibc Bancorp Usa Inc. Portfolio

Follow Cibc Bancorp Usa Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Bancorp Usa Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc Bancorp Usa Inc. with notifications on news.